MedPath

Trial on Management of Trigeminal Neuralgia

Phase 4
Conditions
Health Condition 1: G440- Cluster headaches and other trigeminal autonomic cephalgias (TAC)
Registration Number
CTRI/2020/03/024368
Lead Sponsor
Maulana Azad Institute of Dental Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with definite diagnosis of TN according to the criteria of the International Headache Society (HIS) [HIS 3 with ICD- 10 (G44.0) coding]

2.Age-18-70 years

3.Sex â?? both male and female

4.Signed informed consent prior to entering study

Exclusion Criteria

1.Patients who had undergone invasive treatment for TN during the past 1 year preceding to inclusion.

2.Pregnant/ lactating women (risk for teratogenicity),

3.Patients on antidepressants like sodium valproate or any other hepatic microsomal enzyme inhibitors (to avoid risk for toxicity);

4.History of excessive alcohol intake, hepatic or renal insufficiency or a known intolerance/allergy to study drugs

5.Those who were found to be non-compliant during the screening period (owing to psychological or logistic reasons)

6.Those who on MRI are found to have intranuclear lesion (Secondary & classical TN)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath